April 9th 2025
Physicians can customize treatment depth and intensity with Avava’s system, improving results for various skin concerns.
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Revolutionizing Atopic Dermatitis (RAD) Conference 2025
June 6-7, 2025
Register Now!
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
Levels of sedation require derm surgeons' adherence
July 1st 2002New Orleans - Sedating patients is a serious business, and dermatologic surgeons need to be well aware of the progressive levels of sedation and ensure that patients are monitored appropriately to prevent complications, J. Lance Lichtor, M.D., said.
Buyer's remorse? Older the tattoo, the better
July 1st 2002Atlanta - Older tattoos are removed faster and more completely after laser treatment compared with newer tattoos, according to the results of a preliminary study presented by Erick A. Mafong, M.D., at the annual meeting of the American Society for Laser Medicine and Surgery.
Nd:YAG use expanded to facial telangiectasias
July 1st 2002Atlanta - Physicians may be able to expand the uses of the 1064nm Nd:YAG laser, used to treat telangiectasias and small reticular veins in the lower extremities, by also applying it to the treatment of facial telangiectasias, said David J. Goldberg, M.D., J.D., director, Skin & Laser Surgery Specialists of New York and New Jersey.
Radiofrequency device offers advantages of its own
July 1st 2002Atlanta - A new radiofrequency energy device that can nonablatively change the morphology of the dermis and allow the physician to put a high amount of energy into the skin is a huge step forward in the treatment of cosmetic conditions, said Karl Pope, director of research, Thermage, Hayward, Calif. Thermage is developing an RF device for treatment of skin in dermatology and plastic surgery applications.
Arachnophlebectomy needle proves effective for leg telangiectasias
June 1st 2002Las Vegas - Destruction of veins by a sharp-tipped needle maybe a more effective approach to leg telangiectasias than sclerotherapy,according to Linda Woodson, M.D. She views this new modality as an appropriatestrategy for sites that have been resistant to sclerotherapy, rather thanas a first-line therapy.
Shoe-related CD sometimes hard to size up
June 1st 2002Maui, Hawaii - Shoe-related allergic contact dermatitis is commonlyoverlooked in the differential diagnosis of foot dermatitis, mainly becausepatients are not patch tested, according to James S. Taylor, M.D. at theSkin Disease Education Foundation's 26th Hawaii Dermatology Seminar.
Patients still having too much
June 1st 2002For more than a decade and a half, dermatologists have been stronglyadvocating the use of sunscreens and urging people to avoid sun exposure- yet skin cancer is still the most common cancer in the United States.It affects about a million Americans every year and is responsible for about2 percent of all cancer deaths, with melanoma accounting for about three-quartersof all skin cancer deaths.
Tanning beds, acitretin equal psoriasis clearing
June 1st 2002New Orleans - A small study combining commercial tanning bed therapy and acitretin has provided big results for patients with moderate to severe plaque-type psoriasis. In addition to rapid clearance of skin disease, the treatment is far more accessible for most patients and much less expensive than more traditional forms of light therapy,
Helpful hints for hard-to-heal wounds
May 1st 2002New Orleans - Chronic wound healing can be enhanced through a variety of products that encompass systemic agents such as pentoxifylline and aspirin to tissue-engineered skin and growth factors that stimulate healing, according to Robert S. Kirsner, MD.